CW December 2002
Volume 11Issue Number 12 December 2002 ISSN 10593802 Adjuvant Dose-Dense Chemotherapy Improves Disease-Free Survival Rates in Breast Cancer PatientsNew data from a large phase III study of women with node-positive breast cancer that was presented at the 25th Annual San Antonio Breast Cancer Symposium (December 10-14, 2002), suggest that a dose-dense regimen of standard chemotherapeutic agents is highly effective in reducing the risk of recurrence and improving disease-free survival as well as overall survival rate.
Go to Previous Page Go to Next Page Source & Additional Reading 25th Annual San Antonio Breast Cancer Symposium, December 10-14, 2002. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW December 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
